IPOs and Public Securities

• Counsel to lead underwriters in connection with NYSE and Nasdaq IPOs of mortgage REITs.

• Counsel to Pharmaceuticals company in its US$1.7 billion senior unsecured cash bridge financing, US$2.65 billion committed debt bridge financing and US$2.75 billion in senior unsecured notes related to a merger transaction.

• Counsel to J.P. Morgan and Morgan Stanley, as representatives of the underwriters, in certain NYSE IPOs.

• Counsel to JPMorgan Chase Bank, as joint lead arranger, in US$280 million in term loan financing related to an acquisition.

• Counsel to MedTech company in its US$25 million private placement of investment units.

• Counsel to multiple companies in connection with their Nasdaq IPOs.

Banking and Finance

• Counsel to portfolio companies in connection with their US$300 million term loan credit facility and US$350 million ABL credit facility.

• Counsel to private equity sponsor in connection with acquisition of portfolio company and related US$390 million first lien credit facility, US$160 million second lien credit facility and US$200 million ABL credit facility.

• Counsel to corporate company in connection with Debtor-in-Possession financing, including a US$500 million term loan facility and US$575 million revolving ABL facility.

• Counsel to corporate company in its US$500 million offering of high-yield senior notes.

• Counsel to portfolio companies in connection with their USD$125 million revolver, US$750 million funded B term loan and USD$150 million delayed-draw term commitments related to their acquisition by a private equity sponsor.

• Counsel to private equity sponsor in connection with its US$25 million acquisition financing, US$115 million term loan facility, US$25 million revolving facility and US$55 million senior subordinated notes facility and in connection with its merger with a healthcare company and several refinancings and waivers of existing indebtedness.

• Counsel to a debt fund in connection with a US$150 million working capital revolving facility and US$5 million equity investment in a U.S. based alternative financing provider.

• Counsel to a debt fund in connection with a US$27.5 million working capital revolving facility provided to a U.S. based alternative financing provider.

Mergers and Acquisitions and Equity Investments

• Counsel to an industrial corporation in its US$525 million sale of its North American and European businesses to a private equity sponsor.

• Counsel to private equity sponsors in connection with the sale of multiple portfolio companies.

• Counsel to a communications and advertising company in its US$690 million sale of its business to a strategic buyer.

• Counsel to high-tech company in its sale to a strategic buyer at a US$170 million valuation.

• Counsel to a pharmaceutical company in its $28 million future equity financing round.